These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26284765)

  • 1. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.
    Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD
    Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-programmed-death-receptor-1 (PD-1) antibody (Pembrolizumab) induced pancreatitis diagnosed on 18F-FDG PET/CT.
    Usmani S; Jain A; Riyami KA; Sayani R; Jayakrishnan VV
    J Pak Med Assoc; 2024 Apr; 74(4):825-826. PubMed ID: 38751292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
    Wachsmann JW; Ganti R; Peng F
    Acad Radiol; 2017 Jan; 24(1):111-115. PubMed ID: 27818005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab-induced hepatitis on 18F-FDG PET/CT in a patient with malignant melanoma.
    Raad RA; Pavlick A; Kannan R; Friedman KP
    Clin Nucl Med; 2015 Mar; 40(3):258-9. PubMed ID: 25290291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With Pembrolizumab.
    Sachpekidis C; Hassel JC; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2016 Feb; 41(2):156-8. PubMed ID: 26545022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab-induced colitis on FDG PET/CT.
    Lyall A; Vargas HA; Carvajal RD; Ulaner G
    Clin Nucl Med; 2012 Jun; 37(6):629-30. PubMed ID: 22614208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.
    Tirumani SH; Ramaiya NH; Keraliya A; Bailey ND; Ott PA; Hodi FS; Nishino M
    Cancer Immunol Res; 2015 Oct; 3(10):1185-92. PubMed ID: 26100356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT.
    Das JP; Halpenny D; Do RK; Ulaner GA
    Clin Nucl Med; 2019 Oct; 44(10):836-837. PubMed ID: 31283599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
    Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.
    Barina AR; Bashir MR; Howard BA; Hanks BA; Salama AK; Jaffe TA
    Abdom Radiol (NY); 2016 Feb; 41(2):207-14. PubMed ID: 26867901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipilimumab-Induced Adrenalitis: A Possible Pitfall in 18F-FDG-PET/CT.
    Bacanovic S; Burger IA; Stolzmann P; Hafner J; Huellner MW
    Clin Nucl Med; 2015 Nov; 40(11):e518-9. PubMed ID: 26164177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
    van der Hiel B; Blank CU; Haanen JB; Stokkel MP
    Clin Nucl Med; 2013 Apr; 38(4):e182-4. PubMed ID: 23455528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
    Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
    Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis.
    Perng P; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Aug; 205(2):259-70. PubMed ID: 26204273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stable disease or complete response? : A critical evaluation of the radiologic response to immune checkpoint blockade in advanced melanoma].
    Tietze JK; Heppt M; Angelova D; Ruzicka T; Berger F; Berking C
    Hautarzt; 2017 Aug; 68(8):632-638. PubMed ID: 28382381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
    Dehghani L; Mikail N; Kramkimel N; Soyer P; Lebtahi R; Mallone R; Larger E
    Eur J Cancer; 2018 Nov; 104():243-246. PubMed ID: 30454710
    [No Abstract]   [Full Text] [Related]  

  • 17. Regorafenib-Associated Acute Pancreatitis Diagnosed on 18F-FDG PET/CT.
    Pereira M; Prakash A; Puranik AD; Purandare N; Shah S; Agrawal A; Rangarajan V
    Clin Nucl Med; 2021 May; 46(5):e256-e257. PubMed ID: 33315679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretation.
    Gilardi L; Colandrea M; Vassallo S; Travaini LL; Paganelli G
    Clin Nucl Med; 2014 May; 39(5):472-4. PubMed ID: 23640225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT.
    Hennessy G; Vamadevan S; Loh H; Bui C; Le K; Mansberg R
    Clin Nucl Med; 2017 Mar; 42(3):239-240. PubMed ID: 28098664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CTLA4 antibody therapy related complications on FDG PET/CT.
    Koo PJ; Klingensmith WC; Lewis KD; Bagrosky BM; Gonzalez R
    Clin Nucl Med; 2014 Jan; 39(1):e93-6. PubMed ID: 23657138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.